Skewed T-cell receptor V β8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development? (original) (raw)
Abstract
Transgenic mice expressing the c-myc proto-oncogene under the control of the CD2-dominant control region show stochastic development of mainly clonal thymic lymphoma with long latency, indicating that cooperative events are needed for the development of the fully malignant phenotype. Previous studies have suggested that T-cell receptor-associated signals can contribute to tumour development. We have therefore used this transgenic model of T-cell transformation to determine whether antigen-specific responses could constitute an epigenetic event in lymphomagenesis. The T-cell receptor (TcR) repertoires of lymphoma clones were analysed with a panel of monoclonal antibodies (Abs) recognizing TcR Vbeta chains. The Vbeta repertoire of tumour clones arising in these mice was non-random with overrepresentation of Vbeta8.2 TcR species. The majority of Vbeta8.2+ clones were of a mature CD3+ CD8 single-positive (SP) phenotype. The biased TcR usage, together with a mature cell phenotype is consistent with the hypothesis that TcR-mediated signals cooperate with activated myc during T-cell transformation.
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Veterinary Pathology, University of Glasgow Veterinary School, UK
G Webster
Authors
- G Webster
- DE Onions
- JC Neil
- ER Cameron
Rights and permissions
About this article
Cite this article
Webster, G., Onions, D., Neil, J. et al. Skewed T-cell receptor V β8.2 expression in transgenic CD2-myc induced thymic lymphoma: a role for antigen stimulation in tumour development?.Br J Cancer 76, 739–746 (1997). https://doi.org/10.1038/bjc.1997.455
- Issue date: 01 September 1997
- DOI: https://doi.org/10.1038/bjc.1997.455